Pharmaco attributes of dioleoylphosphatidylethanolamine/ cholesterylhemisuccinate liposomes containing different types of cleavable lipopolymers

Pharmacological Research

Volumn 49, Issue 2, 2004, Pages 185-198

  Zhang, Janny X ^a   Zalipsky, Samuel ^b   Mullah, Nasreen ^b   Pechar, Michal ^c   Allen, Theresa M ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

^b ALZA CORPORATION   (United States)

^c UNIVERSITY OF UTAH   (United States)

Author keywords

Doxorubicin; pH sensitive liposomes; Pharmacokinetics; Polyethyleneglycol; Zeta potential

Indexed keywords

CHOLESTEROL HYDROGEN SUCCINATE; DIOLEOYLPHOSPHATIDYLETHANOLAMINE; LIPOSOME; METHOXYPOLY(ETHYLENE GLYCOL) 2000 DISTEAROYLPHOSPHATIDYLETHANOLAMINE; METHOXYPOLY(ETHYLENE GLYCOL) 2000 DITHIODISTEAROYLPHOSPHATIDIC ACID; METHOXYPOLY(ETHYLENE GLYCOL) 2000 GLYCYLPHENYLALANYLLEUCYLGLYCYLDISTEAROYLPHOSPHATIDYLETHANOLAMINE; N [2 OMEGA METHOXYPOLY(ETHYLENE GLYCOL) 2000 ALPHA AMINOCARBONYLETHYLDITHIOPROPIONYL]DISTEAROYLPHOSPHATIDYLETHANOLAMINE; PHOSPHATIDYLCHOLINE; PHOSPHOLIPID; POLYMER; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; CIRCULATION; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG CLEARANCE; DRUG HALF LIFE; FEMALE; MOUSE; NONHUMAN; PLASMA CLEARANCE; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN SECRETION; STEREOSPECIFICITY; SURFACE CHARGE; ZETA POTENTIAL;

EID: 0344873301     PISSN: 10436618     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.phrs.2003.09.003     Document Type: Article

References (54)

1. Nicol F., Nir S., Szoka F.C. Jr. Effect of cholesterol and charge on pore formation in bilayer vesicles by a pH-sensitive peptide. Biophys. J. 71:1996;3288-3301.
2. Turk M.J., Reddy J.A., Chmielewski J.A., Low P.S. Characterization of a novel pH-sensitive peptide that enhances drug release from folate-targeted liposomes at endosomal pHs. Biochim. Biophys. Acta. 1559:2002;56-68.
3. Litzinger D., Huang L. Phosphatidylethanolamine liposomes: drug delivery, gene transfer and immunodiagnostic applications. Biochim. Biophys. Acta. 1131:1992;201-227.
4. Couvreur P., Fattal E., Malvy C., Cubernet C. pH sensitive liposomes: an intelligent system for the delivery of antisense oligonucleotides. J. Liposome Res. 7:1997;1-18.
5. Drummond D.C., Zignani M., Leroux J. Current status of pH-sensitive liposomes in drug delivery. Prog. Lipid Res. 39:2000;409-460.
6. Hafez I.M., Cullis P.R. Roles of lipid polymorphism in intracellular delivery. Adv. Drug Deliv. Rev. 47:2001;139-148.
7. Ellens H., Bentz J., Szoka F.C. pH-induced destabilization of phosphatidylethanolamine-containing liposomes: role of bilayer contact. Biochemistry. 23(7):1984;1532-1538.
8. Collins D., Maxfield F., Huang L. Immunoliposomes with different acid sensitivities as probes for the cellular endocytotic pathway. Biochim. Biophys. Acta. 987:1989;47-55.
9. Collins D., Connor J., Ting-Beall H.P., Huang L. Proton and divalent cations induce synergistic but mechanistically different destabilizations of pH-sensitive liposomes composed of dioleoyl phosphatidylethanolamine and oleic acid. Chem. Phys. Lipids. 55:1990;339-349.
10. Slepushkin V.A., Simoes S., Dazin P.et al. Sterically stabilized pH-sensitive liposomes: intracellular delivery of aqueous contents and prolonged circulation in vivo. J. Biol. Chem. 272:1997;2382-2388.
11. 2+-induced fusion of sulfatide-containing phosphatidylethanolamine small unilamellar vesicles. J. Lipid Res. 40:1999;1254-1262.
12. Ishida T., Kirchmeier M.J., Moase E.H., Zalipsky S., Allen T.M. Targeted delivery and triggered release of liposomal doxorubicin enhances cytotoxicity against human B lymphoma cells. Biochim. Biophys. Acta. 1515:2001;144-158.
13. Hong M.-S., Lim S.-J., Oh Y.-K., Kim C.-K. pH-sensitive, serum-stable and long-circulating liposomes as a new drug delivery system. J. Pharm. Pharmacol. 54(1):2002;51-58.
14. Van Bambeke F., Kerkhofs A., Schanck A.et al. Biophysical studies and intracellular destabilization of pH-sensitive liposomes. Lipids. 35:2000;213-223.
15. Connor J., Huang L. pH-sensitive immunoliposomes as an efficient and target-specific carrier for antitumor drugs. Cancer Res. 46:1986;3431-3435.
16. Simoes S., Slepushkin V., Gaspar R., Pedrosa de Lima M.C., Duzgunes N. Gene delivery by negatively charged ternary complexes of DNA, cationic liposomes and transferrin or fusigenic peptides. Gene Ther. 5:1998;955-964.
17. Shi G., Guo W., Stephenson S.M., Lee R.J. Efficient intracellular drug and gene delivery using folate receptor-targeted pH-sensitive liposomes composed of cationic/anionic lipid combinations. J. Control. Release. 80:2002;309-319.
18. Skalko-Basnet N., Tohda M., Watanabe H. Delivery of antisense oligonucleotides to neuroblastoma cells. Neuroreport. 11(14):2000;3117-3121.
19. Ponnappa B.C., Dey I., Tu G.C.et al. In vivo delivery of antisense oligonucleotides in pH-sensitive liposomes inhibits lipopolysaccharide-induced production of tumor necrosis factor-alpha in rats. J. Pharmacol. Exp. Ther. 297:2001;1129-1136.
20. Ponnappa B.C., Israel Y. Targeting Kupffer cells with antisense oligonucleotides. Front. Biosci. 7:2002;e223-e233.
21. Collins D., Litzinger D.C., Huang L. Structural and fuctional comparisons of phosphatidylethanolamine and three different diacylsuccinylglycerol. Biochim. Biophys. Acta. 1025:1990;234-242.
22. Ellens H., Bentz J., Szoka F.C. Destabilization of phosphatidylethanolamine liposomes at the hexagonal phase transition temperature. Biochemistry. 25(2):1986;285-294.
23. Mori A., Chonn A., Choi L.S., Israels A., Monck M.A., Cullis P.R. Stabilization and regulated fusion of liposomes containing a cationic lipid using amphipathic polyethyleneglycol derivatives. J. Liposome Res. 8:1998;195-211.
24. Allen T.M., Hansen C.B., Martin F., Redemann C., Yau-Young A. Liposomes containing synthetic lipid derivatives of poly(ethylene glycol) show prolonged circulation half-lives in vivo. Biochim. Biophys. Acta. 1066(1):1991;29-36.
25. Allen T.M., Hansen C.B., Lopes de Menezes D.E. Pharmacokinetics of long circulating liposomes. Adv. Drug Deliv. Rev. 16:1995;267-284.
26. Torchilin V.P., Omelyanenko V.G., Papisov M.I.et al. Poly(ethylene glycol) on the liposome surface: on the mechanism of polymer coated liposome longevity. Biochim. Biophy. Acta. 1195:1994;11-20.
27. Allen T.M. The use of glycolipids and hydrophilic polymers in avoiding rapid uptake of liposomes by the mononuclear phagocyte system. Adv. Drug Deliv. Rev. 13:1994;285-309.
28. Simoes S., Slepushkin V., Duzgunes N., Pedroso de Lima M.C. On the mechanisms of internalization and intracellular delivery mediated by pH-sensitive liposomes. Biochim. Biophys. Acta. 1515:2001;23-37.
29. Duzgunes N., Simoes S., Slepushkin V.et al. Enhanced inhibition of HIV-1 replication in macrophages by antisense oligonucleotides, ribozymes and acyclic nucleoside phosphonate analogs delivered in pH-sensitive liposomes. Nucleosides Nucleotides Nucleic Acids. 20(4-7):2001;515-523.
30. Kirpotin D., Hong K., Mullah N., Papahadjopoulos D., Zalipsky S. Liposomes with detachable polymer coating: destabilization and fusion of dioleoylphosphatidylethanolamine vesicles triggered by cleavage of surface-grafted poly(ethylene glycol). FEBS Lett. 388:1996;115-118.
31. Zalipsky S., Qazen M., Walker J.A.I., Mullah N., Quinn Y.P., Huang S.K. New detachable poly(ethylene glycol) conjugates: cystein-cleavable lipopolymers regenerating natural phospholipid, diacy phosphatidylethanolamine. Bioconjug. Chem. 10:1999;703-707.
32. Darnell J, Lodish H, Baltimore D. Molecular cell biology. New York: Scientific American Books; 1986.
33. Rejmanová P., Pohl J., Baudys M., Kostka V., Kopecek J. Polymers containing enzymatically degradable bonds. 8. Degradation of oligopeptide sequences in N-(2-hydroxypropyl)methacrylamide copolymers by bovine spleen cathepsin B. Macromol. Chem. 184:1983;2009-2020.
34. Lu Z.-R., Shiah J.-G., Sakuma S., Kopeckova P., Kopecek J. Design of novel bioconjugates for targeted drug delivery. J. Control. Release. 78(1-3):2002;165-173.
35. Herman S., Loccufier J., Schacht E. End-group modification of a-hydro-w-methoxy-poly(oxyethylene). 3. Facile methods for the introduction of a thiol-selective reactive end-group. Macromol. Chem. Phys. 195:1994;203-209.
36. Bolotin E.M., Cohen R., Bar L.K., Emanuel S.N., Lasic D.D., Barenholz Y. Ammonium sulphate gradients for efficient and stable remote loading of amphipathic weak bases into liposomes and ligandosomes. J. Liposome Res. 4:1994;455-479.
37. 125I labelled inulin: a convenient marker for deposition of liposomal contents in vivo Biochem. Biophys. Res. Commun. 122(1):1984;319-324.
38. Bartlett G.R. Phosphorus assay in column chromatography. J. Biol. Chem. 234:1959;466-468.
39. Ishida T., Iden D.L., Allen T.M. A combinatorial approach to producing sterically stabilized (Stealth) immunoliposomal drugs. FEBS Lett. 460:1999;129-133.
40. Iden D.L., Allen T.M. In vitro and in vivo comparison of immunoliposomes made by conventional coupling techniques with those made by a new post-insertion technique. Biochim. Biophys. Acta. 1513:2001;207-216.
41. Sou K., Endo T., Takeoka S., Tsuchida E. Poly(ethylene glycol)-modification of the phospholipid vesicles by using the spontaneous incorporation of poly(ethylene glycol)-lipid into the vesicles. Bioconjug. Chem. 11:2000;372-379.
42. Uster P.S., Allen T.M., Daniel B.E., Mendez C.J., Newman M.S., Zhu G.Z. Insertion of poly(ethylene glycol) derivatized phospholipid into preformed liposomes results in prolonged in vivo circulation time. FEBS Lett. 386:1996;243-246.
43. Zalipsky S., Seltzer R., Menon-Rudolph S. Evaluation of a new reagent for covalent attachment of polyethylene glycol to proteins. Biotechnol. Appl. Biochem. 15(1):1992;100-114.
44. Kenworthy A.K., Simon S.A., McIntosh T.J. Structure and phase behaviour of lipid suspensions containing phospholipids with covalently attached poly(ethylene glycol). Biophys. J. 68:1995;1903-1920.
45. Woodle M.C., Newman M.S., Cohen J.A. Sterically stabilized liposomes: physical and biological properties. J. Drug Target. 2(5):1994;397-403.
46. Weissig V., Whiteman K.R., Torchilin V.P. Accumulation of protein-loaded long-circulating micelles and liposomes in subcutaneous Lewis lung carcinoma in mice. Pharm. Res. 15:1998;1552-1556.
47. Edwards K., Johnsson M., Karlsson G., Silvander M. Effect of polyethyleneglycol-phospholipids on aggregate structure in preparations of small unilamellar liposomes. Biophys. J. 73:1997;258-266.
48. Lasic D.D., Woodle M.C., Martin F.J., Valentincic T. Phase behavior of "Stealth lipid"-lecithin mixtures. Periodicum Biologorum. 93(2):1991;287-290.
49. Shimada K., Matsuo S., Sadzuka Y.et al. Determination of incorporated amounts of poly(ethylene glycol)-derivatized lipids in liposomes for the physicochemical characterization of stealth liposomes. Int. J. Pharm. 203:2000;255-263.
50. Bedu-Addo F.K., Huang L. Interaction of PEG phospholipid conjugates with phospholipid: implications in liposomal drug delivery. Adv. Drug Deliv. Rev. 16(2-3):1995;235-247.
51. Kuhl T.L., Leckband D.E., Lasic D.D., Israelachvili J.N. Modulation of interaction forces between bilayers exposing short-chained ethylene oxide headgroups. Biophys. J. 66(5):1994;1479-1488.
52. Yoshioka H. Surface modification of haemoglobin-containing liposomes with polyethylene glycol prevents liposome aggregation in blood plasma. Biomaterials. 12:1991;861-864.
53. Chiu G.N., Bally M.B., Mayer L.D. Selective protein interactions with phosphatidylserine containing liposomes alter the steric stabilization properties of poly(ethylene glycol). Biochim. Biophys. Acta. 1510:2001;56-69.
54. Chiu G.N., Bally M.B., Mayer L.D. Effects of phosphatidylserine on membrane incorporation and surface protection properties of exchangeable poly(ethylene glycol)-conjugated lipids. Biochim. Biophys. Acta. 1560:2002;37-50.